87 related articles for article (PubMed ID: 19748126)
1. Combined chelation based on glycosyl-mono- and bis-hydroxypyridinones for aluminium mobilization: solution and biodistribution studies.
Chaves S; Dron PI; Danalache FA; Sacoto D; Gano L; Santos MA
J Inorg Biochem; 2009 Nov; 103(11):1521-9. PubMed ID: 19748126
[TBL] [Abstract][Full Text] [Related]
2. Combined chelation of bi-functional bis-hydroxypiridinone and mono-hydroxypiridinone: synthesis, solution and in vivo evaluation.
Gama S; Gil M; Gano L; Farkas E; Amélia Santos M
J Inorg Biochem; 2009 Feb; 103(2):288-98. PubMed ID: 19091421
[TBL] [Abstract][Full Text] [Related]
3. A new approach for potential combined chelation therapy using mono- and bis-hydroxypyridinones.
Santos MA; Gama S; Gil M; Gano L
Hemoglobin; 2008; 32(1-2):147-56. PubMed ID: 18274992
[TBL] [Abstract][Full Text] [Related]
4. New tripodal hydroxypyridinone based chelating agents for Fe(III), Al(III) and Ga(III): Synthesis, physico-chemical properties and bioevaluation.
Grazina R; Gano L; Sebestík J; Amelia Santos M
J Inorg Biochem; 2009 Feb; 103(2):262-73. PubMed ID: 19062099
[TBL] [Abstract][Full Text] [Related]
5. Bis(3-hydroxy-4-pyridinone)-EDTA derivative as a potential therapeutic Al-chelating agent. Synthesis, solution studies and biological assays.
Santos MA; Gama S; Gano L; Farkas E
J Inorg Biochem; 2005 Sep; 99(9):1845-52. PubMed ID: 16099511
[TBL] [Abstract][Full Text] [Related]
6. The 3-hydroxypyridin-4-ones more effectively chelate aluminum in a rabbit model of aluminum intoxication than does desferrioxamine.
Yokel RA; Meurer KA; Skinner TL; Fredenburg AM
Drug Metab Dispos; 1996 Jan; 24(1):105-11. PubMed ID: 8825197
[TBL] [Abstract][Full Text] [Related]
7. New tris(hydroxypyridinones) as iron and aluminium sequestering agents: synthesis, complexation and in vivo studies.
Chaves S; Marques SM; Matos AM; Nunes A; Gano L; Tuccinardi T; Martinelli A; Santos MA
Chemistry; 2010 Sep; 16(34):10535-45. PubMed ID: 20665585
[TBL] [Abstract][Full Text] [Related]
8. Aluminum chelation: chemistry, clinical, and experimental studies and the search for alternatives to desferrioxamine.
Yokel RA
J Toxicol Environ Health; 1994 Feb; 41(2):131-74. PubMed ID: 8301696
[TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of aluminum toxicity including chelation therapy: status and research needs.
Yokel RA; Ackrill P; Burgess E; Day JP; Domingo JL; Flaten TP; Savory J
J Toxicol Environ Health; 1996 Aug; 48(6):667-83. PubMed ID: 8772805
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of potential aluminum chelators in vitro by aluminum solubilization ability, aluminum mobilization from transferrin and the octanol/aqueous distribution of the chelators and their complexes with aluminum.
Yokel RA; Datta AK; Jackson EG
J Pharmacol Exp Ther; 1991 Apr; 257(1):100-6. PubMed ID: 2019981
[TBL] [Abstract][Full Text] [Related]
11. A bis(3-hydroxy-4-pyridinone)-EDTA derivative as a strong chelator for M3+ hard metal ions: complexation ability and selectivity.
Gama S; Dron P; Chaves S; Farkas E; Santos MA
Dalton Trans; 2009 Aug; (31):6141-50. PubMed ID: 20449110
[TBL] [Abstract][Full Text] [Related]
12. New hydroxypyridinone-functionalized sepharoses as sorbing agents for hard metal ions.
Grazina R; Santos MA
J Hazard Mater; 2011 Feb; 186(2-3):1902-8. PubMed ID: 21239106
[TBL] [Abstract][Full Text] [Related]
13. Short-term oral 3-hydroxypyridin-4-one dosing increases aluminum excretion and partially reverses aluminum-induced toxicity in the rabbit independent of chelator lipophilicity.
Yokel RA; Meurer KA; Hong CB; Dickey KM; Skinner TL; Fredenburg AM
Drug Metab Dispos; 1997 Feb; 25(2):182-90. PubMed ID: 9029049
[TBL] [Abstract][Full Text] [Related]
14. Alkylaryl-amino derivatives of 3-hydroxy-4-pyridinones as aluminium chelating agents with potential clinical application.
Chaves S; Gil M; Marques S; Gano L; Santos MA
J Inorg Biochem; 2003 Sep; 97(1):161-72. PubMed ID: 14507473
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of 2-methyl-3-hydroxy-4-pyridinecarboxylic acid as a possible chelating agent for iron and aluminium.
Dean A; Ferlin MG; Brun P; Castagliuolo I; Badocco D; Pastore P; Venzo A; Bombi GG; Di Marco VB
Dalton Trans; 2008 Apr; (13):1689-97. PubMed ID: 18354766
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo comparative studies on chelation of aluminum by some polyaminocarboxylic acids.
Graff L; Muller G; Burnel D
Res Commun Mol Pathol Pharmacol; 1995 Jun; 88(3):271-92. PubMed ID: 8564384
[TBL] [Abstract][Full Text] [Related]
17. 1,6-Dimethyl-4-hydroxy-3-pyridinecarboxylic acid and 4-hydroxy-2-methyl-3-pyridinecarboxylic acid as new possible chelating agents for iron and aluminium.
Dean A; Ferlin MG; Brun P; Castagliuolo I; Yokel RA; Badocco D; Pastore P; Venzo A; Bombi GG; Di Marco VB
Dalton Trans; 2009 Mar; (10):1815-24. PubMed ID: 19240917
[TBL] [Abstract][Full Text] [Related]
18. N-Carboxyalkyl derivatives of 3-hydroxy-4-pyridinones: synthesis, complexation with Fe(III), Al(III) and Ga(III) and in vivo evaluation.
Santos MA; Gil M; Marques S; Gano L; Cantinho G; Chaves S
J Inorg Biochem; 2002 Sep; 92(1):43-54. PubMed ID: 12230987
[TBL] [Abstract][Full Text] [Related]
19. Searching for new aluminium chelating agents: a family of hydroxypyrone ligands.
Toso L; Crisponi G; Nurchi VM; Crespo-Alonso M; Lachowicz JI; Mansoori D; Arca M; Santos MA; Marques SM; Gano L; Niclós-Gutíerrez J; González-Pérez JM; Domínguez-Martín A; Choquesillo-Lazarte D; Szewczuk Z
J Inorg Biochem; 2014 Jan; 130():112-21. PubMed ID: 24200878
[TBL] [Abstract][Full Text] [Related]
20. Bifunctional 3-hydroxy-4-pyridinone derivatives as potential pharmaceuticals: synthesis, complexation with Fe(III), Al(III) and Ga(III) and in vivo evaluation with 67Ga.
Santos MA; Gil M; Gano L; Chaves S
J Biol Inorg Chem; 2005 Aug; 10(5):564-80. PubMed ID: 16133203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
